Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China · Delayed Price · Currency is CNY 51.06
+0.15 (0.29%)
At close: Sep 4, 2026
Hangzhou AGS MedTech Revenue
Hangzhou AGS MedTech had revenue of 161.12M CNY in the quarter ending June 30, 2026, a decrease of -7.31%. This brings the company's revenue in the last twelve months to 592.88M, down -12.17% year-over-year. In the year 2025, Hangzhou AGS MedTech had annual revenue of 593.74M, down -6.74%.
Revenue (ttm)
592.88M
Revenue Growth
-12.17%
P/S Ratio
6.96
Revenue / Employee
761.08K
Employees
779
Market Cap
4.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 593.74M | -42.89M | -6.74% |
| Dec 31, 2024 | 636.63M | 127.89M | 25.14% |
| Dec 31, 2023 | 508.75M | 137.64M | 37.09% |
| Dec 31, 2022 | 371.11M | 65.65M | 21.49% |
| Dec 31, 2021 | 305.47M | 133.51M | 77.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 6.47B |
| Wuhan Huakang Century Clean Technology | 2.47B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |
| Guangdong Biolight Meditech | 1.09B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Guangdong Transtek Medical Electronics | 999.28M |
| Shanghai Aohua Photoelectricity Endoscope | 793.05M |